Esketamine for Treatment-Resistant Depression — First FDA-Approved Antidepressant in a New Class

posted in: Pediatric News | 0

 

Esketamine for Treatment-Resistant Depression — First FDA-Approved Antidepressant in a New Class NEJM 6/2019